EL
ABBV icon

EWA LLC’s AbbVie ABBV Stock Holding History

EWA LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Buy
3,645
+183
+5% +$39.4K 0.17% 76
2026
Q1 		$753K Buy
3,462
+437
+14% +$96.9K 0.17% 74
2025
Q4 		$691K Buy
3,025
+352
+13% +$80.2K 0.17% 74
2025
Q3 		$619K Buy
2,673
+108
+4% +$22K 0.17% 65
2025
Q2 		$476K Buy
2,565
+303
+13% +$56.3K 0.15% 73
2025
Q1 		$474K Buy
2,262
+32
+1% +$6.22K 0.18% 61
2024
Q4 		$396K Buy
2,230
+361
+19% +$66.4K 0.15% 70
2024
Q3 		$317K Buy
1,869
+238
+15% +$44.4K 0.11% 83
2024
Q2 		$282K Buy
1,631
+95
+6% +$15.7K 0.12% 86
2024
Q1 		$247K Buy
+1,536
New +$265K 0.11% 91

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EWA LLC's ABBV Position: Q2 2026 in Review

EWA LLC increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $39.4K and bringing the position to 3,645 shares worth $917K. The position accounts for 0.17% of the portfolio, ranked #76.

EWA LLC first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EWA LLC held 3,645 shares of AbbVie worth $917K as of Q2 2026.
  • EWA LLC bought 183 AbbVie shares in Q2 2026, an estimated $39.4K.
  • AbbVie made up 0.17% of EWA LLC's portfolio in Q2 2026, its #76 holding.
  • EWA LLC first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.